1. Home
  2. WMK vs AGIO Comparison

WMK vs AGIO Comparison

Compare WMK & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weis Markets Inc.

WMK

Weis Markets Inc.

HOLD

Current Price

$74.37

Market Cap

1.7B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WMK
AGIO
Founded
1912
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
WMK
AGIO
Price
$74.37
$27.78
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$36.25
AVG Volume (30 Days)
108.5K
920.2K
Earning Date
02-24-2026
02-12-2026
Dividend Yield
1.87%
N/A
EPS Growth
6.99
N/A
EPS
3.81
N/A
Revenue
$4,894,832,000.00
$44,791,000.00
Revenue This Year
N/A
$27.83
Revenue Next Year
N/A
$133.46
P/E Ratio
$19.05
N/A
Revenue Growth
2.20
36.26
52 Week Low
$61.53
$22.24
52 Week High
$90.23
$46.00

Technical Indicators

Market Signals
Indicator
WMK
AGIO
Relative Strength Index (RSI) 75.74 48.36
Support Level $68.29 $26.53
Resistance Level $69.31 $29.93
Average True Range (ATR) 1.56 1.17
MACD 0.54 0.06
Stochastic Oscillator 94.37 43.34

Price Performance

Historical Comparison
WMK
AGIO

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: